MarketInOut Stock Screener Log In | Sign Up

Acrux Ltd

Healthcare • Biotechnology • Quote as of 10/29/2026 10:00
Acrux Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization6.12 mln
Float565 mln
Earnings Date03/02/2027

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-1.75
Likely manipulated

Relative Strength

22 / 100
Significantly lagging

Debt / Equity

1.72
High leverage

Pre-Tax Margin

-52%
Severely loss-making

ROE

-49.11
Deeply negative

Business Description

Acrux Limited is an Australian pharmaceutical company that develops and sells a range of medicines applied directly to the skin, serving customers across Australia, Europe, the United States, and other markets. Its current products include treatments for menopause symptoms, acne, and pain relief, marketed under several brand names. The company is also working to bring new topical treatments to market for conditions such as toenail fungus, anal fissures, and cold sores. Founded in 1998 and headquartered in West Melbourne, Acrux focuses on making established drug compounds more accessible through innovative delivery methods.

Key Fundamentals

EPS-0.00
ROE-49.11
RPS0.02
ROIC-11.27
ROA-9.16
Interest Cover-7.59
EBITDA, mln-1.69
EV / EBITDA-3.20
EV / EBIT-2.54
Revenue, mln4.64
EV / Revenue1.16

Quote Details

Last 0.01
Change 0 (0%)
Open 0.01
Volume 30,000
Turnover 300
Average Volume 947,631

Financial Ratios

Pre-Tax Profit Margin-52
Leverage Ratio4.65
Current Ratio1.37
Price / Book3.00
Price / Cash Flow3.42
Price / Free Cash Flow3.00
Debt / Equity1.72
Price / Sales0.81

Financial Strength

Altman Z-Score-25.52
Piotroski F-Score 7 / 9
Beneish M-Score-1.75

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.09% 52 / 100   
1 Month 11.11% 94 / 100   
2 Months -23.08% 25 / 100   
6 Months -9.09% 44 / 100   
1 Year -33.33% 30 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog